… thyroid cancer have changed. Modern guidelines endorse deintensification in the recommended
use of RAI via 1) more selective use, … A consequence of more selective RAI use is that …

… B-RAF mutations are found in 30%–70% of patients with papillary thyroid cancer (PTC). …
are almost exclusive of follicular thyroid cancer (FTC) and anaplastic thyroid cancer (ATC). …

… thyroid cancer (FTC) and in half of anaplastic thyroid cancer (ATC) and poorly differentiated
thyroid cancer (PDTC), while they are present in only 10%–15% of papillary thyroid cancer (…

… Thyroid Association guidelines recommend the routine use … primary tumors, and selective
use in patients with intrathyroidal … the use of RRA in the management of papillary thyroid cancer…

… , the use of preoperative neck imaging to optimize the completeness of the initial surgery,
and the selective use … As thyroid cancer management moves toward a much more risk-adapted …

… risk groups (selective use cohort). In addition, most modern day thyroid surgeons practice
an “… regarding the “selective use” of RAI ablation in differentiated thyroid cancer patients and …

… Revised American Thyroid Association management guidelines for patients with thyroid
nodules and differentiated thyroid cancer [published correction appears in Thyroid. 2010;20(8):…

… selective use of RAI (2, 10). In light of these changes, 9 years ago, we revised the treatment
strategy used for PTC in our thyroid cancer … information on all thyroid cancer patients seen by …

… that ‘‘postsurgical use of RAI should be selective, given that … selective use on the Continent
for remnant ablation, contrasts with the recommendations of the National Thyroid Cancer …

… of targeted treatment of thyroid cancer with multikinase … and selective inhibitor treatments
for medullary thyroid cancer, radioiodine-refractory thyroid cancer and anaplastic thyroid cancer …